Clinical efficacy analysis of 110 cases of childhood vitiligo with non-surgical combined therapy
JOURNAL OF DERMATOLOGICAL TREATMENT(2022)
Abstract
Background Vitiligo has a negative effect on children's physical and psychological health. Few studies have examined long-term treatment efficacy for childhood vitiligo. Therefore, we evaluated the long-term effectiveness of non-surgical combination therapy in pediatric patients with vitiligo and analyzed factors that affect its efficacy. Methods Pediatric patients (<= 12 years) with vitiligo who were treated with topical corticosteroids/topical calcineurin inhibitors and phototherapy for 12 months were retrospectively studied. Short-term systemic corticosteroids were administered according to individual clinical conditions. All lesions were photographed to assess repigmentation at 3-month intervals. Clinical data, the treatment effectiveness, and factors affecting the therapeutic effect were analyzed. Results Overall, 110 children (51 [53.6%] girls; mean [SD] age, 7.1 +/- 3.0 years; 104 [94.5%] with activity status) were treated for a mean period of 23.13 +/- 14.03 months (range, 5-86 months). The overall >50% repigmentation rate was 64.5%. A longer duration of treatment was associated with a higher repigmentation rate (X-2 (trend) = 36.229, P < .001). The vitiligo disease activity score at the first visit was positively correlated with the overall repigmentation rate (r(s) = 0.301, P = .001). Conclusions Treatment lasting longer than 1 year is recommended in children with vitiligo. The best repigmentation effect can be achieved by combination therapy in the rapid progression stage.
MoreTranslated text
Key words
Vitiligo, childhood, combined treatment, VIDA score
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined